Inspire Pharmaceuticals.

PositionTriangle - Brief Article

DURHAM -- Drug maker Inspire Pharmaceuticals raised about $77.1 million in a secondary stock offering. The company, which sold 6.9 million shares at $12 each, hopes to get U.S. Food and Drug Administration approval by the end...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT